Diagnos Medical Systems (TSX: ADK.V)

Diagnos medical systems (tsx: adk.v) email format

Verified email-pattern data for Diagnos Medical Systems (Tsx: Adk.v) is currently limited. You can still use the company insights and contact sections below.
DIAGNOS (TSXV : ADK | OTCQB : DGNOF) applies deep learning to retinal imaging, generating specialist-grade reports in < 2 seconds. Our CARA platform is live in 140 clinics across 16 countries, having screened more than 400 000 patients to date. ISO certification, multi-jurisdictional clearances underpin a global addressable market we size at ~$11 billion. Commercial scale-up is under way: a three-year supply agreement with EssilorLuxottica, the world’s largest optical network, and an enterprise pilot with New Look anchor our optical-retail channel. On the public-health side, we have bid on a Quebec program to screen 1.1 million diabetics over five years. We released four new tests in February 2025, expanding use-case breadth ahead of an FDA submission later this fiscal year. With proven accuracy, DIAGNOS is looking to change the management of chronic conditions at the convergence of AI and population-scale eye care. We invite you to join us in our mission to revolutionize healthcare by harnessing the power of Artificial Intelligence, and to follow us to stay up to date on our latest developments, news, and insights! Forward-looking statements are subject to risks detailed in our public filings.
Looking for a particular Diagnos Medical Systems (TSX: ADK.V) employee's phone or email?

Diagnos Medical Systems (Tsx: Adk.v) Questions

Top Diagnos Medical Systems (TSX: ADK.V) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant